What Is Fentanyl Citrate Injection Formulations UK And How To Use It?

May 15, 2026

Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview

Fentanyl citrate stays among the most vital tools in modern-day anaesthesia and severe pain management throughout the United Kingdom. As a potent synthetic opioid, its function in the National Health Service (NHS) and personal surgical sectors is well-established, mainly due to its rapid beginning of action and cardiovascular stability. This article provides a comprehensive overview of fentanyl citrate injection formulations offered in the UK, their scientific indicators, regulatory landscape, and administration procedures.

What is Fentanyl Citrate?

Fentanyl citrate is a powerful phenylpiperidine-derivative opioid agonist. It was first synthesized in 1960 and rapidly became a foundation of perioperative care. In click here to effectiveness, fentanyl is approximately 50 to 100 times more potent than morphine. Its high lipophilicity permits it to cross the blood-brain barrier quickly, leading to a nearly immediate analgesic effect when administered intravenously.

In the UK, fentanyl citrate is primarily utilized by means of the parenteral path (injection) for both sedative and analgesic functions. It works mostly by binding to the mu-opioid receptors in the main nerve system, changing the perception of discomfort and the emotional reaction to it.

Clinical Indications in the UK

According to the British National Formulary (BNF), fentanyl citrate injection is shown for several specific clinical scenarios:

Analgesic Action: Used during short personnel procedures and in the recovery room.
Analgesic Supplement: Used during the induction and upkeep of inhalation anaesthesia.
Neuroleptanalgesia: Often used in mix with a neuroleptic (such as droperidol) to achieve a state of quiescence and minimized awareness.
Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
Pre-medication: To offer sedation and analgesia before the induction of basic anaesthesia.

Readily Available Formulations and Strengths in the UK

The UK market offers several formulations of fentanyl citrate, created to satisfy the differing requirements of surgical and emergency departments. These are generally provided as clear, colourless services for injection or infusion.

Table 1: Common Fentanyl Citrate Formulations in the UK

Strength (Fentanyl base)

Presentation

Typical Packaging

Maker Examples

50 micrograms/ml

2 ml Ampoule

Load of 10

Hameln, Advanz Pharma

50 micrograms/ml

10 ml Ampoule

Load of 5 or 10

Hameln, Wockhardt

50 micrograms/ml

20 ml Vial/Ampoule

Load of 5

Hameln, Generic

50 micrograms/ml

50 ml Vial

Individual/Pack of 1

Generic (ICU usage)

Note: While 50 mcg/ml is the standard concentration, specialised formulas for epidural or intrathecal use may often be prepared by healthcare facility pharmacies under particular protocols.

Pharmacokinetics and Pharmacodynamics

Understanding how the body processes fentanyl is essential for safe administration.

Start of Action: When administered intravenously, the result begins nearly instantly, though the maximal analgesic effect might take 3 to 5 minutes.
Duration: A single intravenous dosage of 100 micrograms normally lasts for 30 to 60 minutes.
Metabolic process: Fentanyl is primarily metabolised in the liver via the CYP3A4 enzyme system.
Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mostly as metabolites.

Administration Protocols

In the UK, the administration of fentanyl citrate is strictly managed and normally carried out by anaesthetists or trained professionals in controlled environments.

Dosage Guidelines

Dose needs to be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the kind of surgical treatment.

Low Dose (2 mcg/kg): Useful for small surgical procedures.
Moderate Dose (2— 20 mcg/kg): Used when surgical treatment is more intrusive; requires respiratory monitoring.
High Dose (20— 50 mcg/kg): Used during “trouble-free” significant surgeries (e.g., open-heart surgical treatment) to safeguard the myocardium from the metabolic needs of stress.

Paths of Administration

Intravenous (IV) Bolus: Common for induction.
Intravenous Infusion: Used for longer procedures or in the ICU.
Intramuscular (IM): Less common, however utilized for pre-medication in specific scenarios.

Regulative Status and Safety

In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).

Statutory Requirements for UK Hospitals:

Safe Custody: Must be saved in a locked controlled drug cabinet.
Record Keeping: Every administration needs to be tape-recorded in a Controlled Drugs Register (CDR).
Destruction: Surplus or expired fentanyl needs to be denatured and witnessed by authorised workers.

Negative Effects and Adverse Reactions

While highly effective, fentanyl citrate carries a danger of significant adverse effects.

Respiratory Depression: The most major side result, which can lead to breathing arrest if not monitored.
Bradychardia: Often managed with atropine.
Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation challenging, requiring using neuromuscular blocking agents.
Queasiness and Vomiting: Common in the postoperative duration.
Hypotension: Although more steady than morphine, it can still happen, specifically in hypovolaemic patients.

Comparison with Other Opioids

Clinicians often choose fentanyl over other opioids due to its particular pharmacokinetic profile.

Table 2: Comparison of Parenteral Opioids in UK Practice

Feature

Fentanyl

Morphine

Remifentanil

Relative Potency

100

100-200

Beginning

1— 3 minutes

15— 30 minutes

1 minute

Duration of Action

30— 60 minutes

3— 4 hours

5— 10 minutes

Histamine Release

Negligible

Significant

Negligible

Main Use

Intraoperative/ICU

Post-operative/Chronic

Titratable Infusion

Frequently Asked Questions (FAQ)

1. Is fentanyl citrate injection the same as the fentanyl spots?

No. While they contain the same active drug, the injection is for immediate, intense usage in surgical or emergency situation settings. Patches (transdermal delivery) are designed for chronic, long-lasting pain management and launch the medication slowly over 72 hours.

2. Can fentanyl citrate be used for kids in the UK?

Yes, it is frequently utilized in paediatric anaesthesia. However, the dosage must be strictly computed based on the child's weight, and they must be kept track of carefully for respiratory anxiety.

3. What is the villain for fentanyl?

Naloxone is the specific medicinal villain used to reverse the impacts of fentanyl, consisting of respiratory anxiety. In UK healthcare facilities, naloxone should constantly be easily offered wherever fentanyl is administered.

4. Why is it used over morphine in heart surgical treatment?

Fentanyl is chosen in cardiac surgical treatment due to the fact that it does not cause the release of histamine, which can lead to vasodilation and hypotension. It offers cardiovascular stability even at high dosages.

5. What are the storage requirements?

Fentanyl citrate injection ought to be saved below 25 ° C and secured from light. As a Schedule 2 drug, it needs to be kept in a lawfully compliant CD cupboard.

Fentanyl citrate injection formulations are essential parts of the UK's medical toolkit for handling perioperative pain and assisting in complicated surgeries. Its high potency and rapid start offer unequaled precision for anaesthetists, supplied that strenuous monitoring and regulatory standards are maintained. By comprehending the various concentrations and the rigorous procedures surrounding its usage, healthcare experts guarantee that this effective medication stays both safe and effective for clients throughout the country.

Disclaimer: This article is for informative purposes only and does not constitute medical recommendations. Health care professionals must always describe the Summary of Product Characteristics (SmPC) and current BNF standards for the most current recommending details.